RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Systemic Sclerosis (Scleroderma) - Pipeline Review, Q4 2010
Dec 2010 - 40 pages - $500
ORG Informatics Limited (517195) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $125
CREDIT ORG OF S&M ENTPRS (8489) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
Systemic Sclerosis (Scleroderma) - Pipeline Review, Q2 2011
Apr 2011 - 91 pages - $500
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2011
Aug 2011 - 94 pages - $500
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011
Jun 2011 - 63 pages - $1,000
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2 2011
Oct 2011 - 92 pages - $1,000
ORG Informatics Limited (517195) - Financial and Strategic SWOT Analysis Review
Mar 2011 - 25 pages - $125
Deals and alliances in dermatological diseases
Jun 2006 - 434 pages - $2,495
Medicis Pharmaceutical Corporation: Premium Company Profile
Dec 2007 - 49 pages - $495
More Related Market Research Reports >>>

Your selection

Industry sector
Non-profit org./Government del
Universities del
Therapeutic target
Dermatological del
Scleroderma del
Year
2006 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us